Andrew John Phillips - May 28, 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Rogan Nunn, by power of attorney
Stock symbol
OKUR
Transactions as of
May 28, 2025
Transactions value $
$0
Form type
4
Date filed
5/30/2025, 04:54 PM
Previous filing
Feb 10, 2025
Next filing
Jun 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Phillips Andrew John Director C/O ONKURE THEREAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER /s/ Rogan Nunn, by power of attorney 2025-05-30 0001921956

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OKUR Stock Option (right to buy) Award $0 +7.65K $0.00 7.65K May 28, 2025 Class A Common Stock 7.65K $2.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option will vest on the earlier of May 28, 2026 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.